Valuation : Olympus Corporation

Market Cap 2,144B 13.9B 11.95B 11.24B 10.26B 19.19B 1,314B 19.25B 133B 51.51B 673B 52.19B 51.04B P/E 2027 *
20.6x
P/E 2028 * 17.7x
Enterprise Value 2,225B 14.43B 12.41B 11.67B 10.65B 19.92B 1,364B 19.99B 138B 53.48B 699B 54.17B 52.99B EV / Sales 2027 *
2.06x
EV / Sales 2028 * 1.98x
Free-Float
94.58%
Yield 2027 *
1.53%
Yield 2028 * 1.6%
1 day-1.65%
1 week-3.97%
Current month-3.17%
1 month+8.33%
3 months+12.42%
6 months+49.84%
Current year+2.37%
1 week 11
Extreme 10.995
11.43
1 month 11
Extreme 10.995
11.64
Current year 7.01
Extreme 7.014
11.64
1 year 7.01
Extreme 7.014
11.74
3 years 7.01
Extreme 7.014
17.5
5 years 7.01
Extreme 7.014
23.3
10 years 5.94
Extreme 5.94
23.3
Manager TitleAgeSince
Chief Executive Officer 63 01/06/2025
Director of Finance/CFO 59 01/04/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 01/04/2023
Director/Board Member 41 01/06/2019
Director/Board Member 63 01/06/2019
Change 5-day change 1-year change 3-year change Capi.($)
-1.65%-3.97% - - 14.04B
-0.75%-0.54%+24.60%+15.45% 227B
-1.60%-2.76%+3.72%-18.54% 146B
-0.85%-2.70%-21.45%+23.38% 130B
+1.81%-1.04%-55.42%-11.30% 69.27B
+0.13%-0.94%+11.07%+18.15% 51.82B
-0.97%-2.28%-18.25%-14.22% 50.45B
+0.59%-1.76%+17.17%+29.76% 42.53B
-1.01%-1.27%+33.64%+51.45% 40.22B
-1.55%+2.15%+120.58%+37.37% 32.95B
Average -0.58%-0.93%+12.85%+14.61% 87.75B
Weighted average by Cap. -0.65%-1.41%+6.61%+9.92%

Financials

2027 *2028 *
Net sales 1,079B 7B 6.02B 5.66B 5.17B 9.66B 662B 9.69B 67.09B 25.93B 339B 26.27B 25.7B 1,117B 7.24B 6.23B 5.86B 5.35B 10B 685B 10.03B 69.44B 26.84B 351B 27.19B 26.59B
Net income 105B 680M 585M 550M 502M 940M 64.35B 943M 6.53B 2.52B 32.95B 2.56B 2.5B 122B 789M 678M 638M 582M 1.09B 74.6B 1.09B 7.56B 2.92B 38.2B 2.96B 2.9B
Net Debt 81.71B 530M 456M 428M 391M 731M 50.09B 734M 5.08B 1.96B 25.65B 1.99B 1.95B 64.09B 415M 357M 336M 307M 574M 39.29B 576M 3.98B 1.54B 20.12B 1.56B 1.53B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
07/09/26 €11.00 -1.65% 0
04/09/26 €11.18 -0.31% 0
03/09/26 €11.22 +0.76% 0
02/09/26 €11.13 -2.62% 0
01/09/26 €11.43 +0.66% 0
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,017.00JPY
Average target price
2,157.69JPY
Spread / Average Target
+6.98%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!